Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-04-27 Sale | 2023-04-27 4:34 pm | Cardiovascular Systems Inc | CSII | LAWLOR AUGUSTINE Director | 30,340 | $20 | $606,800 | 0 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2026-03-18 5:56 pm | N/A 2031-02-23 | PRF Technologies Ltd. | PRFX | LAWLOR AUGUSTINE Director | 0 | $0 | 233 (Direct) | View |
| 2025-03-28 Exercise | 2025-04-01 9:53 pm | N/A N/A | LEAP THERAPEUTICS INC. | LPTX | LAWLOR AUGUSTINE Chief Operating Officer | 22,500 | $0 | 698,245 (Direct) | View |
| 2025-03-28 Tax Withholding | 2025-04-01 9:53 pm | N/A N/A | LEAP THERAPEUTICS INC. | LPTX | LAWLOR AUGUSTINE Chief Operating Officer | 7,797 | $0.3166 | 698,245 (Direct) | View |
| 2024-11-13 Exercise | 2024-11-15 5:29 pm | N/A N/A | LEAP THERAPEUTICS INC. | LPTX | LAWLOR AUGUSTINE Chief Operating Officer | 2,136 | $2.82 | 683,542 (Indirect) | View |
| 2024-11-13 Exercise | 2024-11-15 5:29 pm | 2017-11-14 2024-11-14 | LEAP THERAPEUTICS INC. | LPTX | LAWLOR AUGUSTINE Chief Operating Officer | 2,136 | $0 | 683,542 (Indirect) | View |
| 2024-10-02 Option Award | 2024-10-04 5:24 pm | N/A 2034-10-02 | LEAP THERAPEUTICS INC. | LPTX | LAWLOR AUGUSTINE Chief Operating Officer | 85,000 | $0 | 85,000 (Direct) | View |
| 2024-01-29 Option Award | 2024-01-31 9:34 pm | N/A 2034-01-29 | LEAP THERAPEUTICS INC. | LPTX | LAWLOR AUGUSTINE Chief Operating Officer | 85,000 | $0 | 85,000 (Direct) | View |
| 2024-01-26 Exercise | 2024-01-30 8:38 pm | N/A N/A | LEAP THERAPEUTICS INC. | LPTX | LAWLOR AUGUSTINE Chief Operating Officer | 5,000 | $0 | 681,406 (Direct) | View |
| 2023-08-23 Option Award | 2023-08-25 4:31 pm | N/A 2033-08-23 | LEAP THERAPEUTICS INC. | LPTX | LAWLOR AUGUSTINE Chief Operating Officer | 70,000 | $0 | 70,000 (Direct) | View |
| 2023-03-31 Option Award | 2023-04-04 8:09 pm | N/A 2033-03-31 | LEAP THERAPEUTICS INC. | LPTX | LAWLOR AUGUSTINE Chief Operating Officer | 500,000 | $0 | 500,000 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-02 9:26 pm | N/A 2032-08-31 | LEAP THERAPEUTICS INC. | LPTX | LAWLOR AUGUSTINE Chief Operating Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2022-08-05 Option Award | 2022-08-09 4:18 pm | N/A N/A | Cardiovascular Systems Inc | CSII | LAWLOR AUGUSTINE Director | 9,064 | $0 | 134,059 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 9:49 pm | N/A N/A | LEAP THERAPEUTICS INC. | LPTX | LAWLOR AUGUSTINE Chief Operating Officer 10% Owner | 225,000 | $0 | 225,000 (Direct) | View |
| 2021-11-15 Option Award | 2021-11-17 4:36 pm | N/A N/A | Cardiovascular Systems Inc | CSII | LAWLOR AUGUSTINE Director | 1,222 | $0 | 124,995 (Direct) | View |
| 2021-10-01 Option Award | 2021-10-05 4:33 pm | N/A N/A | CATALYST BIOSCIENCES INC. | CBIO | LAWLOR AUGUSTINE Director | 5,839 | $0 | 48,788 (Direct) | View |
| 2021-08-09 Option Award | 2021-08-11 7:19 pm | N/A N/A | Cardiovascular Systems Inc | CSII | LAWLOR AUGUSTINE Director | 5,524 | $0 | 123,773 (Direct) | View |
| 2021-06-09 Option Award | 2021-07-02 09:54 am | N/A 2031-06-09 | CATALYST BIOSCIENCES INC. | CBIO | LAWLOR AUGUSTINE Director | 19,542 | $0 | 56,949 (Direct) | View |
| 2021-05-26 Option Award | 2021-05-28 8:33 pm | N/A 2031-05-25 | LEAP THERAPEUTICS INC. | LPTX | LAWLOR AUGUSTINE Chief Operating Officer 10% Owner | 30,000 | $0 | 30,000 (Direct) | View |